Recently, a new co-culture strategy has been developed, which used tumor antigens to stimulate antigen-presenting dendritic cells (DCs), then co-culture with CD8+ T cells to promote cell lysis and proliferation of these T cells, followed by co-culture with gastric cancer organoids from patient sources. The gene discussed is CD8A; the disease is neoplasm.